Global Oral Polio Vaccines (OPV) Supply, Demand and Key Producers, 2025-2031

Page: 106

Published Date: 3 Nov 2025

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Click To Send

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Oral Polio Vaccines (OPV) market size is expected to reach $ million by 2031, rising at a market growth of %CAGR during the forecast period (2025-2031).

In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report studies the global Oral Polio Vaccines (OPV) production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Oral Polio Vaccines (OPV) and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2024 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oral Polio Vaccines (OPV) that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Oral Polio Vaccines (OPV) total production and demand, 2020-2031, (M Doses)
Global Oral Polio Vaccines (OPV) total production value, 2020-2031, (USD Million)
Global Oral Polio Vaccines (OPV) production by region & country, production, value, CAGR, 2020-2031, (USD Million) & (M Doses), (based on production site)
Global Oral Polio Vaccines (OPV) consumption by region & country, CAGR, 2020-2031 & (M Doses)
U.S. VS China: Oral Polio Vaccines (OPV) domestic production, consumption, key domestic manufacturers and share
Global Oral Polio Vaccines (OPV) production by manufacturer, production, price, value and market share 2020-2025, (USD Million) & (M Doses)
Global Oral Polio Vaccines (OPV) production by Type, production, value, CAGR, 2020-2031, (USD Million) & (M Doses)
Global Oral Polio Vaccines (OPV) production by Application, production, value, CAGR, 2020-2031, (USD Million) & (M Doses)
This report profiles key players in the global Oral Polio Vaccines (OPV) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oral Polio Vaccines (OPV) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Doses) and average price (USD/Doses) by manufacturer, by Type, and by Application. Data is given for the years 2020-2031 by year with 2024 as the base year, 2025 as the estimate year, and 2026-2031 as the forecast year.

Global Oral Polio Vaccines (OPV) Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Oral Polio Vaccines (OPV) Market, Segmentation by Type:
    Trivalent OPV
    Bivalent OPV

Global Oral Polio Vaccines (OPV) Market, Segmentation by Application:
    Public
    Private

Companies Profiled:
    Sanofi
    GSK
    Bibcol
    Serum Institute
    Tiantan Biological
    Panacea Biotec Ltd
    Bio-Med
    Halfkin Bio-Pharmaceuticals

Key Questions Answered:
1. How big is the global Oral Polio Vaccines (OPV) market?
2. What is the demand of the global Oral Polio Vaccines (OPV) market?
3. What is the year over year growth of the global Oral Polio Vaccines (OPV) market?
4. What is the production and production value of the global Oral Polio Vaccines (OPV) market?
5. Who are the key producers in the global Oral Polio Vaccines (OPV) market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Oral Polio Vaccines (OPV) Introduction
    1.2 World Oral Polio Vaccines (OPV) Supply & Forecast
        1.2.1 World Oral Polio Vaccines (OPV) Production Value (2020 & 2024 & 2031)
        1.2.2 World Oral Polio Vaccines (OPV) Production (2020-2031)
        1.2.3 World Oral Polio Vaccines (OPV) Pricing Trends (2020-2031)
    1.3 World Oral Polio Vaccines (OPV) Production by Region (Based on Production Site)
        1.3.1 World Oral Polio Vaccines (OPV) Production Value by Region (2020-2031)
        1.3.2 World Oral Polio Vaccines (OPV) Production by Region (2020-2031)
        1.3.3 World Oral Polio Vaccines (OPV) Average Price by Region (2020-2031)
        1.3.4 North America Oral Polio Vaccines (OPV) Production (2020-2031)
        1.3.5 Europe Oral Polio Vaccines (OPV) Production (2020-2031)
        1.3.6 China Oral Polio Vaccines (OPV) Production (2020-2031)
        1.3.7 Japan Oral Polio Vaccines (OPV) Production (2020-2031)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Oral Polio Vaccines (OPV) Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Oral Polio Vaccines (OPV) Major Market Trends

2 Demand Summary
    2.1 World Oral Polio Vaccines (OPV) Demand (2020-2031)
    2.2 World Oral Polio Vaccines (OPV) Consumption by Region
        2.2.1 World Oral Polio Vaccines (OPV) Consumption by Region (2020-2025)
        2.2.2 World Oral Polio Vaccines (OPV) Consumption Forecast by Region (2026-2031)
    2.3 United States Oral Polio Vaccines (OPV) Consumption (2020-2031)
    2.4 China Oral Polio Vaccines (OPV) Consumption (2020-2031)
    2.5 Europe Oral Polio Vaccines (OPV) Consumption (2020-2031)
    2.6 Japan Oral Polio Vaccines (OPV) Consumption (2020-2031)
    2.7 South Korea Oral Polio Vaccines (OPV) Consumption (2020-2031)
    2.8 ASEAN Oral Polio Vaccines (OPV) Consumption (2020-2031)
    2.9 India Oral Polio Vaccines (OPV) Consumption (2020-2031)

3 World Manufacturers Competitive Analysis
    3.1 World Oral Polio Vaccines (OPV) Production Value by Manufacturer (2020-2025)
    3.2 World Oral Polio Vaccines (OPV) Production by Manufacturer (2020-2025)
    3.3 World Oral Polio Vaccines (OPV) Average Price by Manufacturer (2020-2025)
    3.4 Oral Polio Vaccines (OPV) Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Oral Polio Vaccines (OPV) Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Oral Polio Vaccines (OPV) in 2024
        3.5.3 Global Concentration Ratios (CR8) for Oral Polio Vaccines (OPV) in 2024
    3.6 Oral Polio Vaccines (OPV) Market: Overall Company Footprint Analysis
        3.6.1 Oral Polio Vaccines (OPV) Market: Region Footprint
        3.6.2 Oral Polio Vaccines (OPV) Market: Company Product Type Footprint
        3.6.3 Oral Polio Vaccines (OPV) Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Oral Polio Vaccines (OPV) Production Value Comparison
        4.1.1 United States VS China: Oral Polio Vaccines (OPV) Production Value Comparison (2020 & 2024 & 2031)
        4.1.2 United States VS China: Oral Polio Vaccines (OPV) Production Value Market Share Comparison (2020 & 2024 & 2031)
    4.2 United States VS China: Oral Polio Vaccines (OPV) Production Comparison
        4.2.1 United States VS China: Oral Polio Vaccines (OPV) Production Comparison (2020 & 2024 & 2031)
        4.2.2 United States VS China: Oral Polio Vaccines (OPV) Production Market Share Comparison (2020 & 2024 & 2031)
    4.3 United States VS China: Oral Polio Vaccines (OPV) Consumption Comparison
        4.3.1 United States VS China: Oral Polio Vaccines (OPV) Consumption Comparison (2020 & 2024 & 2031)
        4.3.2 United States VS China: Oral Polio Vaccines (OPV) Consumption Market Share Comparison (2020 & 2024 & 2031)
    4.4 United States Based Oral Polio Vaccines (OPV) Manufacturers and Market Share, 2020-2025
        4.4.1 United States Based Oral Polio Vaccines (OPV) Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Oral Polio Vaccines (OPV) Production Value (2020-2025)
        4.4.3 United States Based Manufacturers Oral Polio Vaccines (OPV) Production (2020-2025)
    4.5 China Based Oral Polio Vaccines (OPV) Manufacturers and Market Share
        4.5.1 China Based Oral Polio Vaccines (OPV) Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Oral Polio Vaccines (OPV) Production Value (2020-2025)
        4.5.3 China Based Manufacturers Oral Polio Vaccines (OPV) Production (2020-2025)
    4.6 Rest of World Based Oral Polio Vaccines (OPV) Manufacturers and Market Share, 2020-2025
        4.6.1 Rest of World Based Oral Polio Vaccines (OPV) Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Oral Polio Vaccines (OPV) Production Value (2020-2025)
        4.6.3 Rest of World Based Manufacturers Oral Polio Vaccines (OPV) Production (2020-2025)

5 Market Analysis by Type
    5.1 World Oral Polio Vaccines (OPV) Market Size Overview by Type: 2020 VS 2024 VS 2031
    5.2 Segment Introduction by Type
        5.2.1 Trivalent OPV
        5.2.2 Bivalent OPV
    5.3 Market Segment by Type
        5.3.1 World Oral Polio Vaccines (OPV) Production by Type (2020-2031)
        5.3.2 World Oral Polio Vaccines (OPV) Production Value by Type (2020-2031)
        5.3.3 World Oral Polio Vaccines (OPV) Average Price by Type (2020-2031)

6 Market Analysis by Application
    6.1 World Oral Polio Vaccines (OPV) Market Size Overview by Application: 2020 VS 2024 VS 2031
    6.2 Segment Introduction by Application
        6.2.1 Public
        6.2.2 Private
    6.3 Market Segment by Application
        6.3.1 World Oral Polio Vaccines (OPV) Production by Application (2020-2031)
        6.3.2 World Oral Polio Vaccines (OPV) Production Value by Application (2020-2031)
        6.3.3 World Oral Polio Vaccines (OPV) Average Price by Application (2020-2031)

7 Company Profiles
    7.1 Sanofi
        7.1.1 Sanofi Details
        7.1.2 Sanofi Major Business
        7.1.3 Sanofi Oral Polio Vaccines (OPV) Product and Services
        7.1.4 Sanofi Oral Polio Vaccines (OPV) Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.1.5 Sanofi Recent Developments/Updates
        7.1.6 Sanofi Competitive Strengths & Weaknesses
    7.2 GSK
        7.2.1 GSK Details
        7.2.2 GSK Major Business
        7.2.3 GSK Oral Polio Vaccines (OPV) Product and Services
        7.2.4 GSK Oral Polio Vaccines (OPV) Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.2.5 GSK Recent Developments/Updates
        7.2.6 GSK Competitive Strengths & Weaknesses
    7.3 Bibcol
        7.3.1 Bibcol Details
        7.3.2 Bibcol Major Business
        7.3.3 Bibcol Oral Polio Vaccines (OPV) Product and Services
        7.3.4 Bibcol Oral Polio Vaccines (OPV) Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.3.5 Bibcol Recent Developments/Updates
        7.3.6 Bibcol Competitive Strengths & Weaknesses
    7.4 Serum Institute
        7.4.1 Serum Institute Details
        7.4.2 Serum Institute Major Business
        7.4.3 Serum Institute Oral Polio Vaccines (OPV) Product and Services
        7.4.4 Serum Institute Oral Polio Vaccines (OPV) Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.4.5 Serum Institute Recent Developments/Updates
        7.4.6 Serum Institute Competitive Strengths & Weaknesses
    7.5 Tiantan Biological
        7.5.1 Tiantan Biological Details
        7.5.2 Tiantan Biological Major Business
        7.5.3 Tiantan Biological Oral Polio Vaccines (OPV) Product and Services
        7.5.4 Tiantan Biological Oral Polio Vaccines (OPV) Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.5.5 Tiantan Biological Recent Developments/Updates
        7.5.6 Tiantan Biological Competitive Strengths & Weaknesses
    7.6 Panacea Biotec Ltd
        7.6.1 Panacea Biotec Ltd Details
        7.6.2 Panacea Biotec Ltd Major Business
        7.6.3 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Product and Services
        7.6.4 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.6.5 Panacea Biotec Ltd Recent Developments/Updates
        7.6.6 Panacea Biotec Ltd Competitive Strengths & Weaknesses
    7.7 Bio-Med
        7.7.1 Bio-Med Details
        7.7.2 Bio-Med Major Business
        7.7.3 Bio-Med Oral Polio Vaccines (OPV) Product and Services
        7.7.4 Bio-Med Oral Polio Vaccines (OPV) Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.7.5 Bio-Med Recent Developments/Updates
        7.7.6 Bio-Med Competitive Strengths & Weaknesses
    7.8 Halfkin Bio-Pharmaceuticals
        7.8.1 Halfkin Bio-Pharmaceuticals Details
        7.8.2 Halfkin Bio-Pharmaceuticals Major Business
        7.8.3 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Product and Services
        7.8.4 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.8.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
        7.8.6 Halfkin Bio-Pharmaceuticals Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Oral Polio Vaccines (OPV) Industry Chain
    8.2 Oral Polio Vaccines (OPV) Upstream Analysis
        8.2.1 Oral Polio Vaccines (OPV) Core Raw Materials
        8.2.2 Main Manufacturers of Oral Polio Vaccines (OPV) Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Oral Polio Vaccines (OPV) Production Mode
    8.6 Oral Polio Vaccines (OPV) Procurement Model
    8.7 Oral Polio Vaccines (OPV) Industry Sales Model and Sales Channels
        8.7.1 Oral Polio Vaccines (OPV) Sales Model
        8.7.2 Oral Polio Vaccines (OPV) Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Oral Polio Vaccines (OPV) Production Value by Region (2020, 2024 and 2031) & (USD Million)
 Table 2. World Oral Polio Vaccines (OPV) Production Value by Region (2020-2025) & (USD Million)
 Table 3. World Oral Polio Vaccines (OPV) Production Value by Region (2026-2031) & (USD Million)
 Table 4. World Oral Polio Vaccines (OPV) Production Value Market Share by Region (2020-2025)
 Table 5. World Oral Polio Vaccines (OPV) Production Value Market Share by Region (2026-2031)
 Table 6. World Oral Polio Vaccines (OPV) Production by Region (2020-2025) & (M Doses)
 Table 7. World Oral Polio Vaccines (OPV) Production by Region (2026-2031) & (M Doses)
 Table 8. World Oral Polio Vaccines (OPV) Production Market Share by Region (2020-2025)
 Table 9. World Oral Polio Vaccines (OPV) Production Market Share by Region (2026-2031)
 Table 10. World Oral Polio Vaccines (OPV) Average Price by Region (2020-2025) & (USD/Doses)
 Table 11. World Oral Polio Vaccines (OPV) Average Price by Region (2026-2031) & (USD/Doses)
 Table 12. Oral Polio Vaccines (OPV) Major Market Trends
 Table 13. World Oral Polio Vaccines (OPV) Consumption Growth Rate Forecast by Region (2020 & 2024 & 2031) & (M Doses)
 Table 14. World Oral Polio Vaccines (OPV) Consumption by Region (2020-2025) & (M Doses)
 Table 15. World Oral Polio Vaccines (OPV) Consumption Forecast by Region (2026-2031) & (M Doses)
 Table 16. World Oral Polio Vaccines (OPV) Production Value by Manufacturer (2020-2025) & (USD Million)
 Table 17. Production Value Market Share of Key Oral Polio Vaccines (OPV) Producers in 2024
 Table 18. World Oral Polio Vaccines (OPV) Production by Manufacturer (2020-2025) & (M Doses)
 Table 19. Production Market Share of Key Oral Polio Vaccines (OPV) Producers in 2024
 Table 20. World Oral Polio Vaccines (OPV) Average Price by Manufacturer (2020-2025) & (USD/Doses)
 Table 21. Global Oral Polio Vaccines (OPV) Company Evaluation Quadrant
 Table 22. World Oral Polio Vaccines (OPV) Industry Rank of Major Manufacturers, Based on Production Value in 2024
 Table 23. Head Office and Oral Polio Vaccines (OPV) Production Site of Key Manufacturer
 Table 24. Oral Polio Vaccines (OPV) Market: Company Product Type Footprint
 Table 25. Oral Polio Vaccines (OPV) Market: Company Product Application Footprint
 Table 26. Oral Polio Vaccines (OPV) Competitive Factors
 Table 27. Oral Polio Vaccines (OPV) New Entrant and Capacity Expansion Plans
 Table 28. Oral Polio Vaccines (OPV) Mergers & Acquisitions Activity
 Table 29. United States VS China Oral Polio Vaccines (OPV) Production Value Comparison, (2020 & 2024 & 2031) & (USD Million)
 Table 30. United States VS China Oral Polio Vaccines (OPV) Production Comparison, (2020 & 2024 & 2031) & (M Doses)
 Table 31. United States VS China Oral Polio Vaccines (OPV) Consumption Comparison, (2020 & 2024 & 2031) & (M Doses)
 Table 32. United States Based Oral Polio Vaccines (OPV) Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers Oral Polio Vaccines (OPV) Production Value, (2020-2025) & (USD Million)
 Table 34. United States Based Manufacturers Oral Polio Vaccines (OPV) Production Value Market Share (2020-2025)
 Table 35. United States Based Manufacturers Oral Polio Vaccines (OPV) Production (2020-2025) & (M Doses)
 Table 36. United States Based Manufacturers Oral Polio Vaccines (OPV) Production Market Share (2020-2025)
 Table 37. China Based Oral Polio Vaccines (OPV) Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers Oral Polio Vaccines (OPV) Production Value, (2020-2025) & (USD Million)
 Table 39. China Based Manufacturers Oral Polio Vaccines (OPV) Production Value Market Share (2020-2025)
 Table 40. China Based Manufacturers Oral Polio Vaccines (OPV) Production, (2020-2025) & (M Doses)
 Table 41. China Based Manufacturers Oral Polio Vaccines (OPV) Production Market Share (2020-2025)
 Table 42. Rest of World Based Oral Polio Vaccines (OPV) Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers Oral Polio Vaccines (OPV) Production Value, (2020-2025) & (USD Million)
 Table 44. Rest of World Based Manufacturers Oral Polio Vaccines (OPV) Production Value Market Share (2020-2025)
 Table 45. Rest of World Based Manufacturers Oral Polio Vaccines (OPV) Production, (2020-2025) & (M Doses)
 Table 46. Rest of World Based Manufacturers Oral Polio Vaccines (OPV) Production Market Share (2020-2025)
 Table 47. World Oral Polio Vaccines (OPV) Production Value by Type, (USD Million), 2020 & 2024 & 2031
 Table 48. World Oral Polio Vaccines (OPV) Production by Type (2020-2025) & (M Doses)
 Table 49. World Oral Polio Vaccines (OPV) Production by Type (2026-2031) & (M Doses)
 Table 50. World Oral Polio Vaccines (OPV) Production Value by Type (2020-2025) & (USD Million)
 Table 51. World Oral Polio Vaccines (OPV) Production Value by Type (2026-2031) & (USD Million)
 Table 52. World Oral Polio Vaccines (OPV) Average Price by Type (2020-2025) & (USD/Doses)
 Table 53. World Oral Polio Vaccines (OPV) Average Price by Type (2026-2031) & (USD/Doses)
 Table 54. World Oral Polio Vaccines (OPV) Production Value by Application, (USD Million), 2020 & 2024 & 2031
 Table 55. World Oral Polio Vaccines (OPV) Production by Application (2020-2025) & (M Doses)
 Table 56. World Oral Polio Vaccines (OPV) Production by Application (2026-2031) & (M Doses)
 Table 57. World Oral Polio Vaccines (OPV) Production Value by Application (2020-2025) & (USD Million)
 Table 58. World Oral Polio Vaccines (OPV) Production Value by Application (2026-2031) & (USD Million)
 Table 59. World Oral Polio Vaccines (OPV) Average Price by Application (2020-2025) & (USD/Doses)
 Table 60. World Oral Polio Vaccines (OPV) Average Price by Application (2026-2031) & (USD/Doses)
 Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
 Table 62. Sanofi Major Business
 Table 63. Sanofi Oral Polio Vaccines (OPV) Product and Services
 Table 64. Sanofi Oral Polio Vaccines (OPV) Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 65. Sanofi Recent Developments/Updates
 Table 66. Sanofi Competitive Strengths & Weaknesses
 Table 67. GSK Basic Information, Manufacturing Base and Competitors
 Table 68. GSK Major Business
 Table 69. GSK Oral Polio Vaccines (OPV) Product and Services
 Table 70. GSK Oral Polio Vaccines (OPV) Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 71. GSK Recent Developments/Updates
 Table 72. GSK Competitive Strengths & Weaknesses
 Table 73. Bibcol Basic Information, Manufacturing Base and Competitors
 Table 74. Bibcol Major Business
 Table 75. Bibcol Oral Polio Vaccines (OPV) Product and Services
 Table 76. Bibcol Oral Polio Vaccines (OPV) Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 77. Bibcol Recent Developments/Updates
 Table 78. Bibcol Competitive Strengths & Weaknesses
 Table 79. Serum Institute Basic Information, Manufacturing Base and Competitors
 Table 80. Serum Institute Major Business
 Table 81. Serum Institute Oral Polio Vaccines (OPV) Product and Services
 Table 82. Serum Institute Oral Polio Vaccines (OPV) Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 83. Serum Institute Recent Developments/Updates
 Table 84. Serum Institute Competitive Strengths & Weaknesses
 Table 85. Tiantan Biological Basic Information, Manufacturing Base and Competitors
 Table 86. Tiantan Biological Major Business
 Table 87. Tiantan Biological Oral Polio Vaccines (OPV) Product and Services
 Table 88. Tiantan Biological Oral Polio Vaccines (OPV) Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 89. Tiantan Biological Recent Developments/Updates
 Table 90. Tiantan Biological Competitive Strengths & Weaknesses
 Table 91. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
 Table 92. Panacea Biotec Ltd Major Business
 Table 93. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Product and Services
 Table 94. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 95. Panacea Biotec Ltd Recent Developments/Updates
 Table 96. Panacea Biotec Ltd Competitive Strengths & Weaknesses
 Table 97. Bio-Med Basic Information, Manufacturing Base and Competitors
 Table 98. Bio-Med Major Business
 Table 99. Bio-Med Oral Polio Vaccines (OPV) Product and Services
 Table 100. Bio-Med Oral Polio Vaccines (OPV) Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 101. Bio-Med Recent Developments/Updates
 Table 102. Bio-Med Competitive Strengths & Weaknesses
 Table 103. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 104. Halfkin Bio-Pharmaceuticals Major Business
 Table 105. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Product and Services
 Table 106. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 107. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
 Table 108. Halfkin Bio-Pharmaceuticals Competitive Strengths & Weaknesses
 Table 109. Global Key Players of Oral Polio Vaccines (OPV) Upstream (Raw Materials)
 Table 110. Global Oral Polio Vaccines (OPV) Typical Customers
 Table 111. Oral Polio Vaccines (OPV) Typical Distributors


List of Figures
 Figure 1. Oral Polio Vaccines (OPV) Picture
 Figure 2. World Oral Polio Vaccines (OPV) Production Value: 2020 & 2024 & 2031, (USD Million)
 Figure 3. World Oral Polio Vaccines (OPV) Production Value and Forecast (2020-2031) & (USD Million)
 Figure 4. World Oral Polio Vaccines (OPV) Production (2020-2031) & (M Doses)
 Figure 5. World Oral Polio Vaccines (OPV) Average Price (2020-2031) & (USD/Doses)
 Figure 6. World Oral Polio Vaccines (OPV) Production Value Market Share by Region (2020-2031)
 Figure 7. World Oral Polio Vaccines (OPV) Production Market Share by Region (2020-2031)
 Figure 8. North America Oral Polio Vaccines (OPV) Production (2020-2031) & (M Doses)
 Figure 9. Europe Oral Polio Vaccines (OPV) Production (2020-2031) & (M Doses)
 Figure 10. China Oral Polio Vaccines (OPV) Production (2020-2031) & (M Doses)
 Figure 11. Japan Oral Polio Vaccines (OPV) Production (2020-2031) & (M Doses)
 Figure 12. Oral Polio Vaccines (OPV) Market Drivers
 Figure 13. Factors Affecting Demand
 Figure 14. World Oral Polio Vaccines (OPV) Consumption (2020-2031) & (M Doses)
 Figure 15. World Oral Polio Vaccines (OPV) Consumption Market Share by Region (2020-2031)
 Figure 16. United States Oral Polio Vaccines (OPV) Consumption (2020-2031) & (M Doses)
 Figure 17. China Oral Polio Vaccines (OPV) Consumption (2020-2031) & (M Doses)
 Figure 18. Europe Oral Polio Vaccines (OPV) Consumption (2020-2031) & (M Doses)
 Figure 19. Japan Oral Polio Vaccines (OPV) Consumption (2020-2031) & (M Doses)
 Figure 20. South Korea Oral Polio Vaccines (OPV) Consumption (2020-2031) & (M Doses)
 Figure 21. ASEAN Oral Polio Vaccines (OPV) Consumption (2020-2031) & (M Doses)
 Figure 22. India Oral Polio Vaccines (OPV) Consumption (2020-2031) & (M Doses)
 Figure 23. Producer Shipments of Oral Polio Vaccines (OPV) by Manufacturer Revenue ($MM) and Market Share (%): 2024
 Figure 24. Global Four-firm Concentration Ratios (CR4) for Oral Polio Vaccines (OPV) Markets in 2024
 Figure 25. Global Four-firm Concentration Ratios (CR8) for Oral Polio Vaccines (OPV) Markets in 2024
 Figure 26. United States VS China: Oral Polio Vaccines (OPV) Production Value Market Share Comparison (2020 & 2024 & 2031)
 Figure 27. United States VS China: Oral Polio Vaccines (OPV) Production Market Share Comparison (2020 & 2024 & 2031)
 Figure 28. United States VS China: Oral Polio Vaccines (OPV) Consumption Market Share Comparison (2020 & 2024 & 2031)
 Figure 29. United States Based Manufacturers Oral Polio Vaccines (OPV) Production Market Share 2024
 Figure 30. China Based Manufacturers Oral Polio Vaccines (OPV) Production Market Share 2024
 Figure 31. Rest of World Based Manufacturers Oral Polio Vaccines (OPV) Production Market Share 2024
 Figure 32. World Oral Polio Vaccines (OPV) Production Value by Type, (USD Million), 2020 & 2024 & 2031
 Figure 33. World Oral Polio Vaccines (OPV) Production Value Market Share by Type in 2024
 Figure 34. Trivalent OPV
 Figure 35. Bivalent OPV
 Figure 36. World Oral Polio Vaccines (OPV) Production Market Share by Type (2020-2031)
 Figure 37. World Oral Polio Vaccines (OPV) Production Value Market Share by Type (2020-2031)
 Figure 38. World Oral Polio Vaccines (OPV) Average Price by Type (2020-2031) & (USD/Doses)
 Figure 39. World Oral Polio Vaccines (OPV) Production Value by Application, (USD Million), 2020 & 2024 & 2031
 Figure 40. World Oral Polio Vaccines (OPV) Production Value Market Share by Application in 2024
 Figure 41. Public
 Figure 42. Private
 Figure 43. World Oral Polio Vaccines (OPV) Production Market Share by Application (2020-2031)
 Figure 44. World Oral Polio Vaccines (OPV) Production Value Market Share by Application (2020-2031)
 Figure 45. World Oral Polio Vaccines (OPV) Average Price by Application (2020-2031) & (USD/Doses)
 Figure 46. Oral Polio Vaccines (OPV) Industry Chain
 Figure 47. Oral Polio Vaccines (OPV) Procurement Model
 Figure 48. Oral Polio Vaccines (OPV) Sales Model
 Figure 49. Oral Polio Vaccines (OPV) Sales Channels, Direct Sales, and Distribution
 Figure 50. Methodology
 Figure 51. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals

Related Reports

Global Oral Polio Vaccines (OPV) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Oral Polio Vaccines (OPV) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Oral Polio Vaccines (OPV) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Oral Polio Vaccines (OPV) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Global Oral Polio Vaccines (OPV) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

date 27 Jun 2025

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Oral Polio Vaccines (OPV) market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.

Product Tags

Oral Polio Vaccines (OPV)

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi Users License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords
artificial intelligence
electron
semiconductor
Battery
5G
new energy
AI
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.
Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.
Contact Us >>